Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 25 images provide visual information about the product associated with Gabapentin NDC 72865-254 by Xlcare Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

100-180 - 100 180

100-180 - 100 180

XLcare is a medication in the form of Gabapentin capsules. Each package contains 180 capsules. It is a prescription-only medication and should be stored at controlled room temperature between 7°F and 86°F. The medication is manufactured by SocantPramacaicas and XUCare pharmaceutical companies. For dosage and usage information, refer to the complete prescribing information provided in the package.*

100-270 - 100 270

100-270 - 100 270

Not available*

100-500 - 100 500

100-500 - 100 500

100-90 - 100 90

100-90 - 100 90

300-180 - 300 180

300-180 - 300 180

Store a1 257 (17 excursions pernite XLcare Detween 15° 10 30°C (59° 085 [see P Aol ¢ Contoted Room Teaperatur] NDO72865-253-18 Dponin ot U9 ch et contaers DosAGe anD Use ‘oo package nsert o full proscring formation Gabapentin - sesicr s sen Capsules, USP jisuee,. . Contal i, Y 11722 200 mg [ A T 180 Capsules Rx Only Rev: 0623*

300-270 - 300 270

300-270 - 300 270

300-30 - 300 30

300-30 - 300 30

300-500 - 300 500

300-500 - 300 500

300-60 - 300 60

300-60 - 300 60

300-90 - 300 90

300-90 - 300 90

Store at 25 degrees Celsius (77 degrees Fahrenheit) with excursions permitted. XLcare should be stored between 15-30 degrees Celsius (59-86 degrees Fahrenheit). This is a controlled temperature product. The product with the code DO 72865-253-00 is to be dispensed in the US, in child-resistant containers. The dosage and usage instructions can be found in the package insert. The product is Gabapentin - Capsules, USP, with a strength of 200 mg. It contains 90 capsules and is for prescription use only. The revision date for the product is 0623.*

400-270 - 400 270

400-270 - 400 270

400-500 - 400 500

400-500 - 400 500

400-90 - 400 90

400-90 - 400 90

Equation - Equ

Equation - Equ

This text appears to be a formula for calculating something related to age, weight, and serum creatinine levels. Specifically, it involves multiplying the individual's age (measured in years) by their weight (measured in kilograms), and then multiplying their serum creatinine level (measured in mg/dL) by 72. Additionally, there is a note indicating that for female patients, the result should be multiplied by 0.85. However, without more context or information, it is difficult to determine the exact purpose or application of this calculation.*

Fig 1 - FIG 1

Fig 1 - FIG 1

Fig 2 - FIG 2

Fig 2 - FIG 2

Fig 3 - FIG 3

Fig 3 - FIG 3

Fig 4 - FIG 4

Fig 4 - FIG 4

Structure - STRUCT

Structure - STRUCT

Table 1 - TAB 1

Table 1 - TAB 1

Table 2 - TAB 2

Table 2 - TAB 2

Table 3 - TAB 3

Table 3 - TAB 3

Table 4 - TAB 4

Table 4 - TAB 4

Table 5 - TAB 5

Table 5 - TAB 5

This is a description of adverse reactions observed in a placebo-controlled add-on trial in pediatric epilepsy patients aged 3 to 12 years. The text provides information on the number of patients who experienced different adverse reactions while taking Gabapenin® as compared to a placebo. The adverse reactions are categorized by body system, such as body as a whole, digestive system, nervous system, and respiratory system. Some of the adverse reactions mentioned include viral infection, fever, increased weight, fatigue, nausea and/or vomiting, somnolence, hostility, emotional lability, dizziness, and respiratory infections. The text also mentions that these adverse reactions were observed in patients who were receiving background antiepileptic drug therapy.*

Tab 6 - TAB 6

Tab 6 - TAB 6

This text provides information on controlled PHN studies involving the medication Gabapentin. It lists the duration of the studies, dosages given to patients, and the number of participants in each study. However, the text does not provide specific values for the duration, dosages, and number of patients. Therefore, the information is not available.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.